Emerging evidence indicates that DNA methylation plays an important role in the initiation
and progression of nasopharyngeal carcinoma (NPC). DNAJA4 is hypermethylated in NPC …

Background The 26S proteasome non-ATPase regulatory subunit 11 is a multiprotein
complex involved in the ATP-dependent degradation of ubiquitinated proteins, and PSMD11 …

Background: Although previous studies reported that 26S proteasome non-ATPase
regulatory subunit 2 (PSMD2) is involved in many human cancers. However, its clinical …

Proteasome 26S subunit, non-ATPase 12 (PSMD12) genes have been implicated in several
types of malignancies but the role of PSMD12 in pancreatic cancer (PC) remains elusive …

Aim: To evaluate the clinic-pathological features and prognostic value regarding PSMD14 in
cancers. Materials & methods: Literature was gathered from public databases until 22 June …

The prognostic biomarkers, or metabolites, have gained relevance due to their significance
in predicting clinical and therapeutic outcomes and guiding informed therapy options. This …

The global burden of hepatocellular carcinoma (HCC) as a preeminent etiology of cancer‐
related mortalities sheds light on the imperative necessity for a more profound …

26S proteasome non-ATPase subunits 1 (PSMD1) and 3 (PSMD3) were recently identified
as prognostic biomarkers and potential therapeutic targets in chronic myeloid leukemia …

Background Proteasome 26S subunit, non-ATPase 3 (PSMD3) has been reported to
participate in various human cancers. Nevertheless, the function of PSMD3 in lung cancer …

Background Biomarker discovery is a challenging task due to the massive search space.
Quantum computing and quantum Artificial Intelligence (quantum AI) can be used to address …